Received-SPF: pass (google.com: domain of patientaccess@elsevier.com designates 147.154.227.175 as permitted sender) client-ip=147.154.227.175;
Content-Type: Multipart/Alternative;
  boundary="------------Boundary-00=_3U8DVA40000000000000"
References: <EC687531-D8AB-40AE-BC0C-20ED3EC70734@gmail.com> <083988FC-A8E1-45F8-87D8-5B92DDA50343@gmail.com>
In-Reply-To: <083988FC-A8E1-45F8-87D8-5B92DDA50343@gmail.com>
From: "Patient Access" 
    <patientaccess@elsevier.com>
Reply-To: "Patient Access" 
    <patientaccess@elsevier.com>
To: tjphuhs@gmail.com
Date: Thu, 12 Feb 2026 21:54:03 +0000 (GMT)
Subject: =?UTF-8?Q?Re:_Paper_Access=C2=A0[260213-004644]?=
MIME-Version: 1.0
Message-Id: <RNTT.2vNBjwo5Dv8K~XHDGvwa~yCWUaYq0U7~86dPhzj~PP_G.1770933243.2jXMGdgT6jU!@utilln05.int.rightnowtech.com>


--------------Boundary-00=_3U8DVA40000000000000
Content-Type: Text/Plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable


FROM: Administrator
DATE: 12/02/2026 09.54 PM

Dear TJ Bourdeau,

Thank you for contacting Elsevier. We prioritize providing high-quality, =
up-to-date information swiftly. We aim to deliver requested articles with=
in 48 hours.

To help us process your request efficiently, please include in your email=
:
        =E2=80=A2Article title and author(s)
        =E2=80=A2Publication date
        =E2=80=A2URL
        =E2=80=A2The statement: =E2=80=9CI confirm I am a patient or non-=
professional caregiver=E2=80=9D

Please avoid sharing additional personal details.

Related articles may already be openly available on our web platform, Sci=
enceDirect. Simply perform a search, then select =E2=80=9COpen access=E2=80=
=9D under =E2=80=9CAccess type=E2=80=9D in the menu on the left-hand side=
=2E All articles in this category are free to download.=20

The Patient Access scheme is intended to support patients and non-profess=
ional caregivers. If you are an institutional user, you may already have =
access to the requested article via your institution. You can check if yo=
u already have access by visiting the article page on ScienceDirect https=
://www.sciencedirect.com  or contact your librarian or information specia=
list for assistance.

Regards,

The Patient Access Team


------------------------------------------------------------------------
FROM: TJ Bourdeau
DATE: 12/02/2026 09.54 PM



Can I please get a copy of this paper?


Effects of retatrutide on body composition in people with type 2 diabetes=
: a substudy of a phase 2, double-blind, parallel-group, placebo-controll=
ed, randomised trial

Author: Tamer Coskun MD a, Qiwei Wu PhD a, Nanette C Schloot MD a, Axel H=
aupt MD a, Zvonko Milicevic MD a, Courtney Khouli PharmD a, Charles Harri=
s MD PhD a
https://www.sciencedirect.com/science/article/abs/pii/S2213858725000920


I confirm I am a patient or non-professional caregiver



TJ


------------------------------------------------------------------------
This email is for use by the intended recipient and contains information =
that may be confidential. If you are not the intended recipient, please n=
otify the sender by return email and delete this email from your inbox. A=
ny unauthorized use or distribution of this email, in whole or in part, i=
s strictly prohibited and may be unlawful. Any price quotes contained in =
this email are merely indicative and will not result in any legally bindi=
ng or enforceable obligation. Unless explicitly designated as an intended=
 e-contract, this email does not constitute a contract offer, a contract =
amendment, or an acceptance of a contract offer.

Elsevier Limited. Registered Office: 125 London Wall, London, EC2Y 5AS, R=
egistration No. 1982084, Registered in England and Wales.
[---002:002232:21174---]

--------------Boundary-00=_3U8DVA40000000000000
Content-Type: Text/Html; charset=UTF-8
Content-Transfer-Encoding: quoted-printable

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
    "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns=3D"http://www.w3.org/1999/xhtml" xmlns:rn=3D"http://schemas.r=
ightnow.com/crm/document">
<head>
<title></title>
<base href=3D"http://service.elsevier.com" />
                                                                    =20
</head>
<body>

<div title=3D"rntmarker_10403" id=3D"rntmarker_10403_2jXMGdgT6jU!">


<div style=3D"font-size: 12pt;">
<SPAN><DIV><SPAN>Dear TJ Bourdeau,</SPAN><BR /><BR /><SPAN>Thank you for =
contacting Elsevier. We prioritize providing high-quality, up-to-date inf=
ormation swiftly. We aim to deliver requested articles within 48 hours.</=
SPAN><BR /><BR /><SPAN>To help us process your request efficiently, pleas=
e include in your email:</SPAN><BR /><SPAN>&#160; &#160; &#160; &#160;  =E2=
=80=A2Article title and author(s)</SPAN><BR /><SPAN>&#160; &#160; &#160; =
&#160;  =E2=80=A2Publication date</SPAN><BR /><SPAN>&#160; &#160; &#160; =
&#160;  =E2=80=A2URL</SPAN><BR /><SPAN>&#160; &#160; &#160; &#160;  =E2=80=
=A2The statement: =E2=80=9CI confirm I am a patient or non-professional c=
aregiver=E2=80=9D</SPAN><BR /><BR /><SPAN>Please avoid sharing additional=
 personal details.</SPAN><BR /><BR /><SPAN>Related articles may already b=
e openly available on our
web platform, ScienceDirect. Simply perform a search, then select =E2=80=9C=
Open access=E2=80=9D under =E2=80=9CAccess type=E2=80=9D in the menu on t=
he left-hand side. All articles in this category are free to download. </=
SPAN><BR /><BR /><SPAN>The Patient Access scheme is intended to support p=
atients and non-professional caregivers. If you are an institutional user=
, you may already have access to the requested article via your instituti=
on. You can check if you already have access by visiting the article page=
 on </SPAN><A href=3D"https://www.sciencedirect.com" title=3D"Click to fo=
llow link: https://www.sciencedirect.com" dir=3D"LTR"><SPAN>ScienceDirect=
</SPAN></A><SPAN>&#160;or contact your librarian or information specialis=
t for assistance.</SPAN><BR /><BR /><SPAN>Regards,</SPAN><BR /><BR /><SPA=
N>The Patient Access
Team</SPAN></DIV></SPAN>
</div>






<br />
<hr />
<div style=3D"font-size: 12pt; background-color: #ffffff">
<b style=3D"FONT-FAMILY: Arial">From:</b> <span style=3D"FONT-FAMILY: Ari=
al">TJ Bourdeau</span><br />
<b style=3D"FONT-FAMILY: Arial">Date:</b> <span style=3D"FONT-FAMILY: Ari=
al">12/02/2026 09.54 PM</span><br />
<br /><div dir=3D"ltr"><br /></div>
<div>Can I please get a copy of this paper?</div>
<div><font color=3D"#DB34F2"><span style=3D"caret-color: rgb(219, 52, 242=
);"><br /></span></font></div>
<div dir=3D"ltr"><span>Effects of retatrutide on body composition in peop=
le with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-=
group, placebo-controlled, randomised trial</span><br /></div>
<div>Author: Tamer Coskun MD a, Qiwei Wu PhD a, Nanette C Schloot MD a, A=
xel Haupt MD a, Zvonko Milicevic MD a, Courtney Khouli PharmD a, Charles =
Harris MD PhD a</div>
<div><a href=3D"https://www.sciencedirect.com/science/article/abs/pii/S22=
13858725000920" target=3D"_blank">https://www.sciencedirect.com/science/a=
rticle/abs/pii/S2213858725000920</a></div>
<div dir=3D"ltr"><br /></div>
<div><span style=3D"font-size: 16px; -webkit-text-size-adjust: auto; back=
ground-color: rgb(44, 44, 46);">I confirm I am a patient or non-professio=
nal caregiver</span></div>
<br />
<div><font color=3D"#DB34F2"><span style=3D"caret-color: rgb(219, 52, 242=
);"><br /></span></font></div>
<div dir=3D"ltr"><span>TJ</span></div>


</div>






<br />
<hr />
<p style=3D"FONT-SIZE: 12pt; FONT-FAMILY: Arial">This email is for use by=
 the intended recipient and contains information that may be confidential=
=2E If you are not the intended recipient, please notify the sender by re=
turn email and delete this email from your inbox. Any unauthorized use or=
 distribution of this email, in whole or in part, is strictly prohibited =
and may be unlawful. Any price quotes contained in this email are merely =
indicative and will not result in any legally binding or enforceable obli=
gation. Unless explicitly designated as an intended e-contract, this emai=
l does not constitute a contract offer, a contract amendment, or an accep=
tance of a contract offer.<br />
<br />
Elsevier Limited. Registered Office: 125 London Wall, London, EC2Y 5AS, R=
egistration No. 1982084, Registered in England and Wales. <a style=3D"TEX=
T-DECORATION: underline" href=3D"https://www.elsevier.com/legal/privacy-p=
olicy" target=3D"_blank">Privacy Policy</a></p>
<img alt=3D"" height=3D"1" width=3D"1" style=3D"display: none" src=3D"htt=
ps://service.elsevier.com/rd/2vNBjwo5Dv8K~XHDGvwa~yCWUaYq0S75Mv_4~zj~PP9x=
=2Egif"/> <div id=3D"checksum" align=3D"right"><span style=3D"font-size: =
1pt">
[---002:002032:10403---]
</span></div>
</div>
</body>
</html>

--------------Boundary-00=_3U8DVA40000000000000--